Page 420 - Avian Virology: Current Research and Future Trends

Index | 411
TAdV-5 285, 287, 288–89, 297, 305 for ND control 43, 66, 69–71, 250, 272, 304, 307, 335, 358–59, 374,
TAdV-B 284, 288–89, 297 387
TAdV-C 284, 288–89, 297 recombination and 319
TAdV-D 284, 288–89, 297, 304, 305 Vaccine vectors
Turkey astrovirus type 2 196, 201 APMVs 112
Turkey aviadenovirus B (TAdV-B) 284, 288 CNPV 374
Turkey aviadenovirus C (TAdV-C) 284, 288 FAdV 223, 283, 308
Turkey aviadenovirus D (TAdV-D) 88, 284, 305 FPV 70, 223, 336, 347, 358, 374, 386, 387
Turkey CoV (TCoV) 136, 163, 196, 201 HVT 70, 223, 336, 337, 387
Turkey herpesvirus vaccine 202 ILTV 337
Turkeypox 365 MDV 70, 223, 240, 337, 358–59
Turkeypox virus 366 NDV 43, 60–61, 64, 71, 112, 123, 223, 387
Turkey rotavirus 201 Vaccinia virus (VV) 70, 371–72, 381
Turkeys. See also Herpesvirus of turkey (HVT) Vaccinia virus (VV) system for reverse genetics 155–56
AIVs in 16–17, 20–24 Varicella-zoster virus (VZV) 320, 348, 352, 355
AMPVs in 119–20, 122–27 Variole aviaire 365
APMVs in 89, 90, 106, 107, 110, 113 VAS (Virginia avirulent strain) of HEV 304
avian adenoviruses in 283, 286, 299, 301, 303–5, 307 V-erbB 234
avian reoviruses in 179, 182, 187–90, 193–99, 201 Vesicular stomatitis virus (VSV) 381
CAV in 265 V-fps 234
CoVs in 136, 163, 201 Viperin 381
HE in 283 Viral arthritis/tenosynovitis 179, 188, 190, 191–93, 195–96
IBDV in 211 Viral interference assays 238
MHC in 388 Viral oncogenesis 345, 354–55
NDV in 44, 67, 70 Viral oncology 231
poxvirus infections in 366–67, 368 Viral-vectored vaccines 387–88. See also Vaccine vectors
Turkey siadenovirus A 284 Virginia avirulent strain (VAS) of HEV 304
Tvärminne avian virus (TVAV) 180, 188 Virula aviar 365
Virulent Newcastle disease (vND) 44
U Virus neutralization (VN) test/assay 86, 125, 133, 154, 159, 162, 238–39,
Ubiquitin-proteasome system 372 273
Unfolded protein response (UPR) 151 Visceral lymphomatosis 232
USP18 382 V-myb 234
V-myc 233, 234
V VND. See Virulent Newcastle disease (vND)
Vaccine development VN (virus neutralization) test/assay 86, 125, 133, 154, 159, 162, 238–39,
for AMPV 119, 123 273
for avian adenoviruses 308 V-src 233, 234
for CAV 273–74 VSV (vesicular stomatitis virus) 381
for IAVs 9, 18 VV (vaccinia virus) 70, 371–72, 381
for IBDV 216, 223–24 VV (vaccinia virus) system for reverse genetics 155–56
for IBV 164 VZV (varicella-zoster virus) 320, 348, 352, 355
for ILTV 317, 335–37
for mammalian pathogens 374 W
for MDV 356, 359 WAdV-1 (white sturgeon adenovirus 1) 295
for NDV 58, 59, 60, 70–71 Wedge-tailed eagle 192, 197, 198, 199
Vaccines and vaccination. See also DNA vaccines; Subunit vaccines West Nile virus 199, 374, 381, 388
adaptive immunity and 377, 387–88 Wet litter syndrome 194
for AI control 1, 23–24, 25, 337, 358–59, 387, 388 White leghorn chickens 303
for ALV infection control 239–40 White sturgeon adenovirus 1 (WAdV-1) 295
for AMPV infection control 119, 126–27 Whole genome sequencing (WGS) 335, 336
for avian adenovirus control 272, 304, 307–8 Wild bird orthoreovirus 180, 188, 189
for avian orthoreovirus infection control 201–2 Wild waterfowl and shorebirds 14–16
for avian pox virus control 365, 368, 373–74 Willow warblers 388
for CAV control 270, 272, 273–74 World Organization for Animal Health (OIE) 1, 45, 161
failure 211, 357
for IB control 60, 133, 136, 154–55, 159–60, 163, 223, 307–8, 335, Y
387 Yeast expression system 223
for IBD control 60, 211, 221–23, 274, 308, 356, 358–59, 385–88 Yolk membrane 136
for ILTV control 60, 330–31, 335–37, 374, 387 Young pigeon disease syndrome (YPDS) 299
imperfect or leaky vaccines 337
interference 23, 154, 202, 335 Z
for MD control 202, 238, 249–50, 269, 272, 336, 345, 356, 358–59, Zebra fnch 379, 388
387–88 Zosteropidae 15